Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in random- ized trials. Circulation. 1998;97:2202 12. 428. Gruppo Italiano per lo Studio della Sopravvivenza nell infarto Miocar- dico. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate sin- gly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet. 1994;343:1115 22. 429. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet. 1995;345:669 85. 430. Cleland JG, Erhardt L, Murray G, et al. Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure: a report from the AIRE Study Investiga- tors. Eur Heart J. 1997;18:41 51. O Gara et al 2013 ACCF/AHA STEMI Guideline e413 431. Dickstein K, Kjekshus J. Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial: Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan. Lancet. 2002;360:752 60. 432. Braunwald E, Domanski MJ, Fowler SE, et al. Angiotensin-converting- enzyme inhibition in stable coronary artery disease. N Engl J Med. 2004; 351:2058 68. 433. Adamopoulos C, Ahmed A, Fay R, et al. Timing of eplerenone initiation and outcomes in patients with heart failure after acute myocardial infarc- tion complicated by left ventricular systolic dysfunction: insights from the EPHESUS trial. Eur J Heart Fail. 2009;11:1099 105. 434. Cannon CP, Steinberg BA, Murphy SA, et al. Meta-analysis of cardiovas- cular outcomes trials comparing intensive versus moderate statin therapy. J Am Coll Cardiol. 2006;48:438 45. 435. Baigent C, Blackwell L, Emberson J, et al. 